Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Halozyme Therapeutics
HALO
5
Precision Drilling
PDS
(Q2)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q2)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|
Assets | |||||||
Current assets | |||||||
Cash, cash equivalents and short term investments | -44.93%181.09K | 228.18%68.37K | 228.18%68.37K | --328.83K | -99.39%20.83K | --20.83K | --3.4M |
-Cash and cash equivalents | -44.93%181.09K | 228.18%68.37K | 228.18%68.37K | --328.83K | -99.39%20.83K | --20.83K | --3.4M |
Receivables | -14.02%359.61K | -26.90%251.39K | -26.90%251.39K | --418.23K | 88.16%343.91K | --343.91K | --182.77K |
-Accounts receivable | ---- | ---- | ---- | --5.25K | ---- | ---- | --0 |
-Taxes receivable | -30.30%201.68K | -58.92%105.81K | -58.92%105.81K | --289.37K | 167.11%257.56K | --257.56K | --96.42K |
-Other receivables | 27.77%157.93K | 68.59%145.58K | 68.59%145.58K | --123.61K | 0.00%86.35K | --86.35K | --86.35K |
Prepaid assets | 626.48%3.53M | 686.50%2.72M | 686.50%2.72M | --486.28K | -39.45%346.36K | --346.36K | --571.98K |
Other current assets | ---- | ---- | ---- | ---5.25K | ---- | ---- | ---- |
Total current assets | 231.69%4.07M | 328.06%3.04M | 328.06%3.04M | --1.23M | -82.89%711.1K | --711.1K | --4.16M |
Non current assets | |||||||
Net PPE | 7.61%6.39M | -15.47%5.59M | -15.47%5.59M | --5.94M | 43.74%6.62M | --6.62M | --4.6M |
-Gross PPE | 25.58%10.8M | 6.46%9.04M | 6.46%9.04M | --8.6M | 64.20%8.49M | --8.49M | --5.17M |
-Accumulated depreciation | -65.68%-4.41M | -83.81%-3.45M | -83.81%-3.45M | ---2.66M | -229.82%-1.88M | ---1.88M | ---568.77K |
Goodwill and other intangible assets | -75.19%43.6K | --0 | --0 | --175.71K | --0 | --0 | --294 |
Other non current assets | -100.00%-2 | ---- | ---- | --90.35K | ---- | ---- | ---- |
Total non current assets | 3.70%6.44M | -15.47%5.59M | -15.47%5.59M | --6.21M | 43.73%6.62M | --6.62M | --4.6M |
Total assets | 41.35%10.51M | 17.87%8.64M | 17.87%8.64M | --7.44M | -16.34%7.33M | --7.33M | --8.76M |
Liabilities | |||||||
Current liabilities | |||||||
Payables | -68.70%2.24M | 3.67%1.19M | 3.67%1.19M | --7.15M | -33.94%1.15M | --1.15M | --1.74M |
-accounts payable | 448.99%444.04K | -39.56%73.08K | -39.56%73.08K | --80.88K | -81.08%120.93K | --120.93K | --639.28K |
-Due to related parties current | ---- | --0 | --0 | --4.11M | -6.69%466.86K | --466.86K | --500.34K |
-Other payable | -39.26%1.79M | 98.85%1.12M | 98.85%1.12M | --2.95M | -6.59%563.45K | --563.45K | --603.19K |
Current accrued expenses | 34.40%47.33K | -28.66%32.53K | -28.66%32.53K | --35.22K | --45.59K | --45.59K | --0 |
Current debt and capital lease obligation | 1,703.13%14.39M | 251.27%6.36M | 251.27%6.36M | --797.8K | 132.70%1.81M | --1.81M | --778.12K |
-Current debt | --13.45M | 436.74%5.44M | 436.74%5.44M | ---- | --1.01M | --1.01M | ---- |
-Current capital lease obligation | 17.39%936.55K | 15.80%923.89K | 15.80%923.89K | --797.8K | 2.53%797.8K | --797.8K | --778.12K |
Current deferred liabilities | --12.93M | ---- | ---- | ---- | ---- | ---- | ---- |
Current liabilities | 270.95%29.6M | 152.25%7.59M | 152.25%7.59M | --7.98M | 19.30%3.01M | --3.01M | --2.52M |
Non current liabilities | |||||||
Long term debt and capital lease obligation | -49.91%826.99K | -38.64%1.26M | -38.64%1.26M | --1.65M | -28.04%2.05M | --2.05M | --2.85M |
-Long term capital lease obligation | -49.91%826.99K | -38.64%1.26M | -38.64%1.26M | --1.65M | -28.04%2.05M | --2.05M | --2.85M |
Non current deferred liabilities | --0 | --9.27M | --9.27M | ---- | --0 | --0 | ---- |
Employee benefits | 70.06%500.58K | 50.29%412.68K | 50.29%412.68K | --294.36K | 42.95%274.59K | --274.59K | --192.09K |
Total non current liabilities | -26.62%1.43M | 355.75%11.04M | 355.75%11.04M | --1.95M | -20.26%2.42M | --2.42M | --3.04M |
Total liabilities | 212.63%31.03M | 243.03%18.62M | 243.03%18.62M | --9.93M | -2.32%5.43M | --5.43M | --5.56M |
Shareholders'equity | |||||||
Share capital | -89.37%11.02K | 26.55%11.02K | 26.55%11.02K | --103.67K | -91.30%8.71K | --8.71K | --100K |
-common stock | -89.37%11.02K | 26.55%11.02K | 26.55%11.02K | --103.67K | -91.30%8.71K | --8.71K | --100K |
Retained earnings | -95.32%-38.88M | -77.09%-27.31M | -77.09%-27.31M | ---19.9M | -275.66%-15.42M | ---15.42M | ---4.1M |
Paid-in capital | 5.98%18.34M | 0.00%17.31M | 0.00%17.31M | --17.31M | 149.20%17.31M | --17.31M | --6.95M |
Gains losses not affecting retained earnings | ---- | ---- | ---- | --0 | ---- | ---- | --260K |
Total stockholders'equity | -724.11%-20.52M | -626.12%-9.99M | -626.12%-9.99M | ---2.49M | -40.70%1.9M | --1.9M | --3.2M |
Total equity | -724.11%-20.52M | -626.12%-9.99M | -626.12%-9.99M | ---2.49M | -40.70%1.9M | --1.9M | --3.2M |
Currency Unit | AED | AED | AED | AED | AED | AED | AED |